Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer.
Open to Accrual
Chemotherapy: Systemic, Hormone
Defintions of terms and FAQ about clinical trials.
Darcy Spicer, M.D.
Other Trial Staff:
Kristy Watkins, R.N., Grace Facio, R.N., Nancy Perez, R.N., Yanli Wang, D.M., Amanda Luna, D.M.
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.